Interferon-gamma

DRUG15 trials

Sponsors

National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), Charite University, Berlin, Germany, DNAtrix, Inc., SPP Pharmaclon Ltd.

Conditions

Aids/Hiv ProblemCOVID-19 COVID-19 SARS-CoV2Chronic Granulomatous DiseaseCommunity-acquired PneumoniaGlioblastoma or GliosarcomaHIV CoinfectionHuman Immunodeficiency VirusKeloids

Phase 1

Active, not recruitingRPCEC00000052

Center for Genetic Engineering and Biotechnology (CIGB)Skin basal cell carcinoma, Squamous cells carcinoma.

Start: 2002-08-05Target: 21Updated: 2026-03-30

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

CompletedNCT02197169

DNAtrix, Inc.Glioblastoma or Gliosarcoma

Start: 2014-09-11End: 2018-03-15Updated: 2018-07-16

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

CompletedNCT05065905

SPP Pharmaclon Ltd.Aids/Hiv Problem, HIV Coinfection, Human Immunodeficiency Virus +3

Start: 2006-01-19End: 2006-04-06Updated: 2024-01-25

Phase 2

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Charite University, Berlin, GermanyReactive Arthritis

Start: 2003-01-31Target: 40Updated: 2006-09-08

Application of CIGB-128 in keloid patients undergoing surgical exeresis.

Active, not recruitingRPCEC00000061

Center for Genetic Engineering and Biotechnology (CIGB)Keloids

Start: 2004-04-02Target: 45Updated: 2026-03-30

CIGB-128 administration to patients with surgically-treated keloids.

RecruitingRPCEC00000062

Center for Genetic Engineering and Biotechnology (CIGB)Keloids

Start: 2003-11-13Target: 30Updated: 2026-03-30

Active, not recruitingRPCEC00000066

Center for Genetic Engineering and Biotechnology (CIGB)Skin basal cell carcinoma (BCC)

Start: 2001-03-26Target: 60Updated: 2026-03-30

HEBERFERON in renal cell carcinoma

Active, not recruitingRPCEC00000229

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaRenal Cell Carcinoma state III and IV after nefrectomy

Start: 2017-03-03Target: 270Updated: 2026-03-30

ESPERANZA study

RecruitingRPCEC00000307

Center for Genetic Engineering and Biotechnology (CIGB), in Havanapatients infected with the SARS-CoV-2 coronavirus. covid-19

Start: 2020-04-10Target: 120Updated: 2026-03-30

Phase 3

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

CompletedNCT00001296

National Cancer Institute (NCI)Melanoma

Start: 1992-02-29End: 2000-10-31Target: 122Updated: 2008-03-04

Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients

Active, not recruitingRPCEC00000383

National Center for Scientific Research (CNIC)COVID-19 COVID-19 SARS-CoV2

Start: 2021-09-01Target: 292Updated: 2026-03-30

Phase 4

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

CompletedNCT00001317

National Institute of Allergy and Infectious Diseases (NIAID)Chronic Granulomatous Disease

Start: 1992-05-31End: 2001-07-31Target: 100Updated: 2008-03-04

Unknown Phase

Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis

SPP Pharmaclon Ltd.Pulmonary Tuberculosis

Start: 2022-04-15End: 2023-05-01Target: 84Updated: 2022-06-01

Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia

CompletedNCT05395702

SPP Pharmaclon Ltd.Community-acquired Pneumonia

Start: 2017-05-12End: 2019-05-30Updated: 2022-05-27

A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis

SPP Pharmaclon Ltd.Respiratory Tuberculosis

Start: 2022-06-01End: 2024-03-01Target: 350Updated: 2023-11-09

Related Papers

Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Clinical Cancer Research2026-01-29

A Clinical Multicenter Trial of Recombinant Human Interferon Gamma in Tuberculosis (GAM2022): Experience with the Use of Human Recombinant Interferon Gamma in TB Practice.

2025-01-01

CTIM-20. SYSTEMIC IMMUNE CORRELATES ASSOCIATED WITH LONG-TERM SURVIVAL AFTER THERAPEUTIC ADENOVIRUS (DNX2401) PLUS INTERFERON GAMMA FOR RECURRENT GLIOBLASTOMA EFFECT TRIAL (TARGET): A RANDOMIZED PHASE 1 TRIAL

Neuro-Oncology2023-11-011 citations

Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients.

2023-08-1214 citations

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.

2019-05-28111 citations

Phase 1b open-label randomized study of the oncolytic adenovirus DNX-2401 administered with or without interferon gamma for recurrent glioblastoma.

Journal of Clinical Oncology2017-05-2041 citations

Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.

2009-07-3012 citations